This is a prospective study to compare the safety and efficacy of treating small aneurysms.
StrokeNet, developed by NIH, is the new structure for federal funding of all aspects of stroke research including prevention, acute treatment, and recovery / rehabilitation. The University of Cincinnati has been named as the national coordinating center and there are 25 regional coordinating centers across the United States, including the University of Utah. RIA is very excited to have been designated as a satellite site of the University of Utah.
As individual research protocols are approved for funding through StrokeNet, we will determine implementation feasibility for our site. If the study is a good fit for our site, we will then engage and partner with other practices and facilities as appropriate to the specific protocol.
For more information about how we are participating with StrokeNet, please contact Alicia Drew, Director, Research and Physician Services at Radiology Imaging Associates
To learn more about StrokeNet, please visit their website here.
You Might Also Enjoy...
This is a prospective study to compare the safety and efficacy of treating small aneurysms.
Safety and Effectiveness of the Treatment of Wide-Neck, Intracranial, Saccular Aneurysms with the Next Generation Neuroform Stent System.
Intravenous (IV) tissue plasminogen activator (tPA) administration has been shown to be safe and effective for treatment of Acute Ischemic Stroke (AIS) within 3 hours of symptom onset, and newer evidence has shown potential benefit out to 4.5 hours.
RIA has a rich history of participation in clinical research and innovation dating back to the 1980s. Many of our physicians believe it is important to contribute to science and advance medicine.
The full name of this study is: Barrel™: Study of the Reverse Medical Barrel™ Vascular Reconstruction Device for Adjunctive Treatment to Embolic Coils for Wide-Neck, Intracranial, Bifurcating/Branching Aneurysms.
This is a prospective, multi-center study of patients treated in accordance with the cleared indications for the Penumbra SMART CoilTM System (SMART), Penumbra Coil 400TM (PC 400), and Penumbra Occlusion DeviceTM (POD).